AGF Investments LLC’s Ligand Pharmaceuticals LGND Stock Holding History

AGF Investments LLC’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-55	Closed	-$3K	–	656
2019 Q3	$3K	Sell	55 -54	-50%	-$3.39K	﹤0.01%	606
2019 Q2	$8K	Hold	109	–	–	﹤0.01%	551
2019 Q1	$9K	Buy	+109	New	+$8.26K	﹤0.01%	509
2018 Q4	–	Sell	-215	Closed	-$37K	–	762
2018 Q3	$37K	Sell	215 -213	-50%	-$32.1K	﹤0.01%	445
2018 Q2	$57	Buy	428 +38	+10%	+$4.24K	0.01%	350
2018 Q1	$38K	Sell	390 -57	-13%	-$5.64K	0.01%	329
2017 Q4	$39K	Buy	+447	New	+$38.7K	0.01%	262

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

AGF Investments LLC's LGND Position: Q4 2019 in Review

AGF Investments LLC sold out of Ligand Pharmaceuticals (LGND) in Q4 2019, closing a stake of 55 shares — an estimated $3K sold.

AGF Investments LLC first reported a position in LGND in Q4 2017 and held it in 7 quarters. The position peaked at $39K in Q4 2017. 266 funds tracked by Wall St. Rank hold LGND as of Q4 2019.

AGF Investments LLC reported no remaining Ligand Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
AGF Investments LLC sold 55 Ligand Pharmaceuticals shares in Q4 2019, an estimated $3K.
AGF Investments LLC first reported a position in Ligand Pharmaceuticals in Q4 2017 and held it in 7 quarters.
AGF Investments LLC's Ligand Pharmaceuticals position peaked at $39K in Q4 2017.
266 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2019.

Based on AGF Investments LLC's 13F filing for Q4 2019, filed 12 Feb 2020.